Gyre Therapeutics, Inc. (GYRE) Gross margin 2022–2024
Gyre Therapeutics, Inc. (GYRE) gross margin by fiscal year — reported gross profit divided by reported revenue.
96.3%FY2024 · since FY2022: 95.3% → 96.3%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2024 | 96.3% | +0.4 pp |
| FY2023 | 95.9% | +0.6 pp |
| FY2022 | 95.3% | — |
Gross margin = reported gross profit ÷ reported revenue for the same fiscal year.
Source: SEC XBRL filings · For reference only · Not investment advice